These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38258669)

  • 1. Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort.
    Dias KR; Shrestha R; Schofield D; Evans CA; O'Heir E; Zhu Y; Zhang F; Standen K; Weisburd B; Stenton SL; Sanchis-Juan A; Brand H; Talkowski ME; Ma A; Ghedia S; Wilson M; Sandaradura SA; Smith J; Kamien B; Turner A; Bakshi M; Adès LC; Mowat D; Regan M; McGillivray G; Savarirayan R; White SM; Tan TY; Stark Z; Brown NJ; Pérez-Jurado LA; Krzesinski E; Hunter MF; Akesson L; Fennell AP; Yeung A; Boughtwood T; Ewans LJ; Kerkhof J; Lucas C; Carey L; French H; Rapadas M; Stevanovski I; Deveson IW; Cliffe C; Elakis G; Kirk EP; Dudding-Byth T; Fletcher J; Walsh R; Corbett MA; Kroes T; Gecz J; Meldrum C; Cliffe S; Wall M; Lunke S; North K; Amor DJ; Field M; Sadikovic B; Buckley MF; O'Donnell-Luria A; Roscioli T
    Genet Med; 2024 May; 26(5):101076. PubMed ID: 38258669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing.
    Wang J; Wang Y; Wang L; Chen WY; Sheng M
    BMC Med Genomics; 2020 May; 13(1):70. PubMed ID: 32429945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective study.
    Sun Y; Peng J; Liang D; Ye X; Xu N; Chen L; Yan D; Zhang H; Xiao B; Qiu W; Shen Y; Pang N; Liu Y; Liang C; Qin Z; Luo J; Chen F; Wang J; Zhang Z; Wei H; Du J; Yan H; Duan R; Wang J; Zhang Y; Liao S; Sun K; Wu L; Yu Y
    Hum Mutat; 2022 May; 43(5):568-581. PubMed ID: 35143101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.
    Malinowski J; Miller DT; Demmer L; Gannon J; Pereira EM; Schroeder MC; Scheuner MT; Tsai AC; Hickey SE; Shen J;
    Genet Med; 2020 Jun; 22(6):986-1004. PubMed ID: 32203227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
    Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
    Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
    Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K
    Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome.
    Dyment DA; O'Donnell-Luria A; Agrawal PB; Coban Akdemir Z; Aleck KA; Antaki D; Al Sharhan H; Au PB; Aydin H; Beggs AH; Bilguvar K; Boerwinkle E; Brand H; Brownstein CA; Buyske S; Chodirker B; Choi J; Chudley AE; Clericuzio CL; Cox GF; Curry C; de Boer E; de Vries BBA; Dunn K; Dutmer CM; England EM; Fahrner JA; Geckinli BB; Genetti CA; Gezdirici A; Gibson WT; Gleeson JG; Greenberg CR; Hall A; Hamosh A; Hartley T; Jhangiani SN; Karaca E; Kernohan K; Lauzon JL; Lewis MES; Lowry RB; López-Giráldez F; Matise TC; McEvoy-Venneri J; McInnes B; Mhanni A; Garcia Minaur S; Moilanen J; Nguyen A; Nowaczyk MJM; Posey JE; Õunap K; Pehlivan D; Pajusalu S; Penney LS; Poterba T; Prontera P; Doriqui MJR; Sawyer SL; Sobreira N; Stanley V; Torun D; Wargowski D; Witmer PD; Wong I; Xing J; Zaki MS; Zhang Y; ; ; Boycott KM; Bamshad MJ; Nickerson DA; Blue EE; Innes AM
    Am J Med Genet A; 2021 Jan; 185(1):119-133. PubMed ID: 33098347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome sequencing identifies major causes of severe intellectual disability.
    Gilissen C; Hehir-Kwa JY; Thung DT; van de Vorst M; van Bon BW; Willemsen MH; Kwint M; Janssen IM; Hoischen A; Schenck A; Leach R; Klein R; Tearle R; Bo T; Pfundt R; Yntema HG; de Vries BB; Kleefstra T; Brunner HG; Vissers LE; Veltman JA
    Nature; 2014 Jul; 511(7509):344-7. PubMed ID: 24896178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
    Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
    Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
    Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM;
    Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making headway with genetic diagnostics of intellectual disabilities.
    Willemsen MH; Kleefstra T
    Clin Genet; 2014 Feb; 85(2):101-10. PubMed ID: 23895455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
    Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL
    Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.
    Anazi S; Maddirevula S; Faqeih E; Alsedairy H; Alzahrani F; Shamseldin HE; Patel N; Hashem M; Ibrahim N; Abdulwahab F; Ewida N; Alsaif HS; Al Sharif H; Alamoudi W; Kentab A; Bashiri FA; Alnaser M; AlWadei AH; Alfadhel M; Eyaid W; Hashem A; Al Asmari A; Saleh MM; AlSaman A; Alhasan KA; Alsughayir M; Al Shammari M; Mahmoud A; Al-Hassnan ZN; Al-Husain M; Osama Khalil R; Abd El Meguid N; Masri A; Ali R; Ben-Omran T; El Fishway P; Hashish A; Ercan Sencicek A; State M; Alazami AM; Salih MA; Altassan N; Arold ST; Abouelhoda M; Wakil SM; Monies D; Shaheen R; Alkuraya FS
    Mol Psychiatry; 2017 Apr; 22(4):615-624. PubMed ID: 27431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
    Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
    Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
    Lavelle TA; Feng X; Keisler M; Cohen JT; Neumann PJ; Prichard D; Schroeder BE; Salyakina D; Espinal PS; Weidner SB; Maron JL
    Genet Med; 2022 Jun; 24(6):1349-1361. PubMed ID: 35396982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies novel and known mutations in families with intellectual disability.
    Rasheed M; Khan V; Harripaul R; Siddiqui M; Malik MA; Ullah Z; Zahid M; Vincent JB; Ansar M
    BMC Med Genomics; 2021 Aug; 14(1):211. PubMed ID: 34452636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy.
    Herkert JC; Abbott KM; Birnie E; Meems-Veldhuis MT; Boven LG; Benjamins M; du Marchie Sarvaas GJ; Barge-Schaapveld DQCM; van Tintelen JP; van der Zwaag PA; Vos YJ; Sinke RJ; van den Berg MP; van Langen IM; Jongbloed JDH
    Genet Med; 2018 Nov; 20(11):1374-1386. PubMed ID: 29517769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.